Careers  |  Sign In  |  Register

Latest Additions

[case_player][/case_player] A research team at UCSF has developed an antiviral aerosol spray, dubbed AeroNabs, that they report has the ability to ward off coronoavirus infection by blocking the ACE2 receptor pathway. The protective molecule is synthesized in a lab by imprinting the genetic blueprints of...
Joshua K. Sabari, MD, assistant professor in the Department of Medicine at NYU Langone Health’s Perlmutter Cancer Center, addresses the need for additional predictive biomarkers for non-small cell lung cancer (NSCLC) patients with no known driver mutation. Dr. Sabari says, to date, PD-L1 is the only...
Rana R. McKay, MD, assistant professor of medicine and medical oncologist at the University of California San Diego, discusses the PDIGREE study design for the treatment of renal cell carcinoma (RCC). Patients initially receive nivolumab plus ipilimumab. Those patients who exhibit a complete response...
Christian U. Blank, MD, PhD, medical oncologist in the Division of Immunology at the Netherlands Cancer Institute, provides a three year update for the first clinical trial for the assessment of checkpoint inhibition in melanoma. During the OpACIN study, none of the patients with an initial response...
Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center in LA, and currently working at a digital health innovation non-profit in Tel-Aviv, Israel, created The Fink Tank series...
[case_player][/case_player] Martin Fischer, PhD, associate research professor in the department of chemistry at Duke Trinity College of Arts and Sciences, was tasked with examining the particle-blocking abilities of various face-covers so the college could provide the type of mask that would best protect...

New Guidelines from the American Society of Hematology for the Treatment of AML

AML Guideline Reinforces Individualized Treatment

Guidelines from the American Society of Hematology (ASH) review panel recommend standards of care for individualized acute myeloid leukemia (AML) treatments. For patients with newly diagnosed AML, ASH recommends intensive antileukemic therapy. Patients who cannot tolerate intensive therapy should be treated...
Ruben A. Mesa, MD, director of the Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, discusses barriers to achieving racially diverse clinical trials for patients with myeloproliferative neoplasms (MPNs), myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML). Dr. Mesa cites...

2020 ASH Guidelines for Treating Older AML Patients

ASH Releases Evidence-Based Guidelines for Treating Older Patients With AML

The American Society of Hematology (ASH) has released 2020 guidelines for treating newly diagnosed acute myeloid leukemia (AML) in older adults. Specifically, the guidelines help patients and doctors make informed decisions at every stage of treatment, including newly diagnosed, post-remission, and hospice....

Complementary Blood and Tissue Molecular Testing for Newly Diagnosed NSCLC

Dr. Socinski on Recommendations for Molecular Testing in Lung Cancer

Mark A. Socinski, MD, executive medical director at AdventHealth Cancer Institute, recommends immediate comprehensive molecular testing at the time of lung cancer diagnosis. Stating that oncogenic driver mutation identification is essential to effective targeted therapies, Dr. Socinski suggests complementary...